完整胸腹主动脉瘤开放修复与腔内修复的结局与费用比较
基于Premier医疗数据库2009年7月至2015年3月879例完整胸腹主动脉瘤修复(腔内481例、开放398例),开放修复住院死亡率和主要并发症更高、住院更长、校正后总住院费用更高;校正住院并发症后两种方式费用无差异。
要点
- 开放修复住院死亡率15% vs 腔内5%(P < .001),主要并发症为腔内的2至3倍。
- 开放修复中位总费用44,355美元 vs 腔内36,612美元(P = .004)。
- 校正并发症后两种方式总住院费用无差异(-$460;95%CI -$4390至$3470;P = .82)。
核心结论
- 在完整胸腹主动脉瘤大队列中,开放修复校正后总住院费用显著高于腔内修复,尽管腔内移植物另有费用。
- 费用差异可能由开放修复住院时间更长和并发症率更高驱动。
研究设计与样本
- 在Premier医疗数据库中识别2009年7月至2015年3月所有因完整胸腹主动脉瘤接受修复的患者。
- 共879例胸腹主动脉瘤修复,其中腔内修复481例(55%)、开放修复398例(45%)。
- 分类变量与连续变量分别采用χ2检验、Student t检验和中位数检验分析,并采用多变量广义线性模型分析总住院费用。
主要发现
- 腔内修复组平均年龄71.2(±10.0)岁 vs 开放修复组66.5(±10.9)岁(P < .001)。
- 腔内修复组女性48% vs 开放修复组42%(P = .05),高血压87% vs 80%(P = .009)。
- 开放修复组住院中位数11(7-20)天 vs 腔内修复组5(2-9)天(P < .001)。
- 开放修复住院死亡率15% vs 腔内修复5%(P < .001),所有主要并发症为腔内的2至3倍。
- 开放修复中位总费用44,355(32,177-54,824)美元 vs 腔内修复36,612(24,395-53,554)美元(P = .004)。
关键数值与推荐
- 开放修复费用高于腔内修复的项目:病房与膳食11,561 vs 4720美元,手术室9230 vs 4929美元,药房2309 vs 900美元,血库1189 vs 195美元,康复/物理治疗378 vs 236美元,呼吸治疗875 vs 168美元(均P < .001)。
- 中心物资(含腔内移植物和支架)费用腔内修复最高:17,472 vs 5501美元(P < .001)。
- 诊断影像费用625 vs 595美元、麻醉费用479 vs 478美元,两种方式相似。
- 多变量分析中开放修复校正后总住院费用较腔内修复高5974美元(95%CI 1828-10,120;P = .005)。
- 校正住院并发症后两种方式无差异(-$460;95%CI -4390至3470;P = .82)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Many previous studies have evaluated the outcomes of open and endovascular repair of thoracoabdominal aortic aneurysms (TAAAs). However, little is known about the differences in cost of these procedures and the potential factors driving these differences. The aim of this study was to evaluate the outcomes and cost of open aortic repair (OAR) vs endovascular repair of intact TAAA. METHODS: All patients undergoing repair for intact TAAA were identified in the Premier Healthcare Database (July 2009-March 2015). Categorical and continuous variables were analyzed using the χ2 test, Student t-test, and median test as appropriate. A multivariable generalized linear model was used to examine total in-hospital cost. RESULTS: A total of 879 TAAA repairs were identified (481 [55%) endovascular repairs vs 398 [45%] OARs). Patients undergoing endovascular repair were on average 5 years older (71.2 [±10.0] years vs 66.5 [±10.9] years; P < .001) and more likely to be female (48% vs 42%; P = .05) and hypertensive (87% vs 80%; P = .009). Otherwise, there were no significant differences in comorbidities between the two groups. Patients undergoing OAR were more likely to stay longer in the hospital (median [interquartile range], 11 [7-20] days vs 5 [2-9] days; P < .001). In-hospital mortality (15% vs 5%; P < .001) and all major complications were two to three times higher after OAR. The median total cost of OAR was significantly higher compared with endovascular repair (cost [interquartile range], $44,355 [$32,177-$54,824] vs $36,612 [$24,395-$53,554]; P = .004). The majority of the cost attributed to TAAA repair was also higher in patients undergoing open repair: room and board ($11,561 vs $4720), operating room ($9230 vs $4929), pharmacy ($2309 vs $900), blood bank ($1189 vs $195), rehabilitation/physical therapy ($378 vs $236), and respiratory therapy ($875 vs $168; all P < .001). Only the cost of central supplies, which includes endovascular grafts and stents, was the highest among patients undergoing endovascular repair ($17,472 vs $5501; P < .001). The cost of diagnostic imaging ($625 vs $595) and anesthesia ($479 vs $478) was similar in both approaches. In a multivariable analysis, the adjusted total hospitalization cost for OAR was $5974 (95% confidence interval, $1828-$10,120; P = .005) higher compared with endovascular repair. However, after adjusting for in-hospital complications, no difference was seen between the two approaches (-$460; 95% confidence interval, -$4390 to $3470; P = .82). CONCLUSIONS: In this large cohort of intact TAAAs, we showed a significantly higher adjusted total hospitalization cost of open compared with endovascular repair despite the additional cost of endografts. This is likely driven by longer length of stay and higher morbidity after OAR.
引用
- Locham S, Dakour-Aridi H, Nejim B, et al. Outcomes and cost of open versus endovascular repair of intact thoracoabdominal aortic aneurysm. J Vasc Surg. 2018. PMID: 29789217. doi:10.1016/j.jvs.2018.01.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。